Asciminib was superior to bosutinib in inducing a major molecular response

Pregnant women were no more likely to suffer severe symptoms of COVID-19 or be ill for longer than […]

In a pivotal Phase II/III study, twice as many patients receiving the drug achieved the primary endpoint of […]

The firms will use Engitix’ extracellular matrix (ECM) discovery platform to develop new therapies for fibrotic liver diseases

A robust, low-cost imaging platform utilizing lab-on-a-chip technology created by University of California, Irvine scientists may be available […]

“It is wise to consider all non-surgical treatment options before resorting to an artificial hip or knee joint […]

Biogen conference likely linked to ‘tens of thousands’ of COVID-19 cases, researchers say esagonowsky Tue, 08/25/2020 – 15:28

Researchers say it can take cells in different forms or ‘life stages’ to cause cancer to grow and […]

FDA faces a reputation crisis amid Trump pressure for fast COVID action—and that’s bad news for pharma bbulik […]

FDA chief Hahn walks back plasma claims, but his correction still missed the mark, experts say esagonowsky Tue, […]